Geneos Wealth Management Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$0
-100.0%
250
-42.5%
0.00%
Q2 2022$1,000
-50.0%
4350.0%0.00%
Q1 2022$2,000
-60.0%
4350.0%0.00%
Q4 2021$5,000
-44.4%
435
-18.7%
0.00%
Q3 2021$9,0000.0%5350.0%0.00%
Q2 2021$9,000
-10.0%
5350.0%0.00%
Q1 2021$10,0000.0%5350.0%0.00%
Q4 2020$10,000
-33.3%
535
-40.7%
0.00%
-100.0%
Q3 2020$15,000
-21.1%
9020.0%0.00%0.0%
Q2 2020$19,000
+26.7%
9020.0%0.00%0.0%
Q1 2020$15,000
-21.1%
9020.0%0.00%0.0%
Q4 2019$19,000
+18.8%
9020.0%0.00%0.0%
Q3 2019$16,000
-56.8%
902
-14.3%
0.00%
-50.0%
Q2 2019$37,000
-2.6%
1,052
-8.7%
0.00%
-33.3%
Q1 2019$38,0000.0%1,1520.0%0.00%0.0%
Q4 2018$38,000
-49.3%
1,152
-6.5%
0.00%
-40.0%
Q3 2018$75,000
+25.0%
1,2320.0%0.01%0.0%
Q2 2018$60,000
-11.8%
1,232
+92.2%
0.01%
-16.7%
Q1 2018$68,0006410.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders